NASDAQ: ABCM
Abcam plc
Healthcare · Biotechnology
Market Cap
$5.52B
52w High
$25.32
52w Low
$12.48
P/E
564.98
Volume
7.43M
Outstanding Shares
230.15M
Not enough data to analyse price vs. fundamentals for this ticker.
Company profile
Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments.
CEOAlan Thomas Hirzel BS,
SectorHealthcare
IndustryBiotechnology
Employees1,760
IPO dateOct 22, 2020
Valuation
Forward P/E—
EV/EBITDA72.05
Enterprise value$3.08B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-31.79%
Gross margin71.21%▲15.24%vs FY2021
Operating margin2.03%▲50.01%vs FY2021
ROE-1.17%▼143.75%vs FY2021
Analyst consensus
RatingHold
Target price—
1
Buy
4
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 31, 2023
Q4 FY23 · EPS est — · Revenue est —
View